PharmaCyte Biotech OverviewPharmaCyte Biotech EBIT
EBIT (Earnings Before Interest and Taxes) analysis for PMCB.
Quarterly EBIT
-$2.12M
↓ 120.58% YoY
As of Jan 31, 2026
Annual EBIT (TTM)
-$12.90M
↓ 186.49% YoY
Trailing 12 months ending Jan 31, 2026
PharmaCyte Biotech OverviewEBIT (Earnings Before Interest and Taxes) analysis for PMCB.
As of Jan 31, 2026
Trailing 12 months ending Jan 31, 2026